Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
So low cost! It's worth geting penis vibrator in our Sex Toys Store.
Popular Articles

Recession Forcing People With Asthma To Skip Vital Medicines
New research1 conducted by Asthma UK suggests that people with asthma are struggling to afford the medicines they need to stay well and out of hospital, and that this situation has been made even worse since the recession began.
pharmacy online Dentisti fiume
Immigration Changes Will Deprive UK Of Doctors, Says BMA Leader
Dr Hamish Meldrum, Chairman of BMA Council, has written to the Secretary of State for Health, Alan Johnson, to request that he intervenes to ensure that the UK does not lose further doctors as a result of recent changes to the immigration system. The changes restrict international medical students, who are studying in the UK, from continuing with their medical training beyond the two-year postgraduate Foundation Programme.
News of the day
Health Care Industry Increases Lobbying Spending
Drug companies "boosted their lobbying in Washington during the three months (that) ended June 30 amid a flurry of congressional action on health care," while overall, "Washington"s lobbying business continued to slump as the economy pinched budgets at some big companies and trade associations," The Wall Street Journal reports. "Drug manufacturers increased lobbying spending 13% to $68 million in the second quarter from a year earlier, according to the data ò€¦ Overall, the health-care sector reported a 5% increase in lobbying expenditures to $133 million, making it the single largest spender on lobbying of the 10 major industry sectors tracked by the Center for Responsive Politics. Health-insurance companies increased lobbying activity by 11% to $7.8 million, according to the data" (Mullins and Farnam, 8/3).
Mental Health

No More Test Tubes On Four Feet? EPA Moves Toward Animal-free Toxicity Tests

The U.S. Environmental Protection Agency (EPA) plans to switch to a new generation of animal-free tests for predicting the toxicity of chemicals to humans, according to an article scheduled for the June 22 issue of Chemical & Engineering News, ACS" weekly newsmagazine. C&EN associate editor Britt Erickson points out that there are more than 80,000 chemicals on the market, with about 700 more added each year. Over the next ten years, EPA plans to increasingly rely on so-called toxicity-based pathways to evaluate these substances. This approach involves using human cell cultures to screen newly marketed chemicals for adverse effects. The new tests will produce results in a fraction of the time now required with animal studies. But the switch won"t be easy, the C&EN article notes. Some experts question the validity of these next-generation tests. Meanwhile, new technologies for predicting toxicity may emerge and complement conventional animal tests, according to the article. American Chemical Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009